Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies.

Cell metabolism·2026

Same author

Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study.

Signal transduction and targeted therapy·2026

Same author

Quantum computing applications in drug discovery.

Briefings in bioinformatics·2026

Same author

A Multistage Virtual Screening Strategy Integrating Molecular Similarity, Deep Learning Scoring, and Molecular Docking toward the Discovery of Novel LRRK2 Inhibitors.

Journal of chemical information and modeling·2026

Same author

Cross-stage single-cell and spatial metabolome analyses reveal periderm specialization and tanshinone biosynthesis in Salvia miltiorrhiza roots.

The New phytologist·2026

Same author

SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients.

Journal of pharmaceutical analysis·2026

Search research articles

Related Experiment Video

Updated: Jun 24, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Themis: advancing precision oncology through comprehensive molecular subtyping and optimization.

Yue Xi^1,2, Kun Zheng³, Fulan Deng⁴

¹Department of Reproductive Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, 250013, China.

Briefings in Bioinformatics

|June 4, 2024

Summary

A new platform, Themis, evaluates tumor molecular subtyping methods for precision oncology. It identifies the best methods for specific clinical scenarios, improving patient-specific treatment strategies and cancer therapy.

Keywords:

benchmark testing bioinformatics pan-cancer tumor subtyping

More Related Videos

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Published on: October 13, 2023

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

Related Experiment Videos

Last Updated: Jun 24, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Published on: October 13, 2023

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

Area of Science:

Oncology
Bioinformatics
Computational Biology

Background:

Precision oncology relies on accurate tumor molecular subtyping for tailored treatments.
Existing subtyping methods lack comprehensive, independent comparative analysis.
This gap hinders optimal selection and refinement of subtyping strategies.

Purpose of the Study:

Introduce Themis (Tumor HEterogeneity analysis on Molecular subtypIng System), an evaluation platform for tumor molecular subtyping methods.
Quantitatively compare representative subtyping methodologies.
Provide guidance for selecting and refining methods for clinical application.

Main Methods:

Developed Themis, an evaluation platform for tumor molecular subtyping.
Included methods: Stemness, Anoikis, Metabolism, and pathway-based classifications.
Utilized 38 diverse datasets from The Cancer Genome Atlas (TCGA) and other key studies.

Main Results:

Uncovered relative strengths, limitations, and applicability of different subtyping methods.
Demonstrated Themis's capability to identify optimal methods for specific clinical contexts.
Showcased practical utility through a breast cancer dataset analysis.

Conclusions:

Themis is a vital tool for selecting appropriate molecular subtyping methods in oncology.
The platform facilitates the fine-tuning of methods for improved phenotype-associated results.
This work advances individualized cancer therapy and patient management strategies.